IN8bio, Inc. (INAB:NASDAQ) closed at $1.09 on October 19, 2026, down 1.80% on the day. The stock trades 60.1% below its 52-week high of $2.73 and 23.9% above its 52-week low of $0.880. Over the past year, it lost 49.3%. IN8bio, Inc. is part of the Health Care sector.
In 252 trading sessions since October 17, 2025, INAB closed higher on 107 days (42%). Its best day was December 22, 2025 (+28.10%) and its worst was March 23, 2026 (-17.00%). The stock moved 10% or more in a single session 14 times.
IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.
Find more stocks like INAB with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.